Medicare AdvantageCoverageMedium impact
MA07.024g, Medical and Surgical Treatment of Temporomandibular Joint Disorder
Independence Blue Cross·Oral & Maxillofacial Surgery, ENT (Ear, Nose & Throat), Neurology +2 more·Medical Policy
Effective date
Aug 6, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA07.024g for Medical and Surgical Treatment of Temporomandibular Joint Disorder has been reissued and will become effective August 6, 2025. This policy update may affect coverage criteria, prior authorization requirements, or billing procedures for TMJ-related services under Medicare Advantage plans.
Action Required
Before August 6, 2025: Billing team must review the complete MA07.024g policy document at the provided URL to identify specific changes to TMJ treatment coverage, prior authorization requirements, or billing procedures. Update billing system rules and provider documentation requirements accordingly. Notify oral-maxillofacial surgery and other relevant providers of any changes to coverage criteria.